Posted on

HIV PrEP Referrals Lag for Black MSM, Trans Adults

Posted on

State health departments were most likely to refer heterosexual adults for HIV preexposure prophylaxis (PrEP) appointments and least likely to refer transgender and Black adults, according to the results of a 12-city PrEP demonstration project. The project, Project PrIDE, was meant to close the PrEP gap between White and cisgender adults and their Black, Latinx, Native American, and transgender…

Read more

Posted on

Hydroxychloroquine Fails to Protect Medical Workers

Posted on

The malaria drug hydroxychloroquine failed to protect healthcare workers caring for COVID-19 patients from becoming infected themselves, according to results of a formal, placebo-controlled trial published in Clinical Infectious Diseases. The 1,483 participants worked in emergency departments, intensive care units, and other high-risk sites in the United States and the Canadian province of Manitoba. They…

Read more

Posted on

25 Drugs, Drug Classes Added to FDA’s Safety Signal List

Posted on

The US Food and Drug Administration (FDA) has added 25 drugs or drug classes to its quarterly list of agents in which it has found a potential sign of serious risk or new safety information. The new list, created from the FDA Adverse Event Reporting System (FAERS), covers April through June, and is current as of October…

Read more

Posted on Leave a comment

First-in-Class Oral EZH2 Inhibitor Effective in Two Cancers

Posted on Leave a comment

(Tazverik) showed potential for improving outcomes for patients with advanced or metastatic epithelioid sarcoma and also yielded clinically meaningful responses in heavily pretreated patients with follicular lymphoma. The findings come from two open-label, single-arm, phase 2 trials that led to the US Food and Drug Administration’s (FDA’s) recent accelerated approval for the indications. Tazemetostat is a…

Read more

Posted on

Global Handwashing Day 2020: Steps to wash your hands to protect against COVID19

Posted on

With the world facing the COVID19 pandemic, washing hands and maintaining hand hygiene has become all the more important and need of the hour. It is also one of the cheapest and easiest ways to prevent coronavirus. Here’s everything you need to know about washing your hands to protect against COVID19. Global Handwashing Day is…

Read more

Posted on

Common Cold History Could Confer Some COVID-19 Immunity Protection

Posted on

The SARS-CoV-2 virus shares an important feature with some viruses that cause the common cold, and the structural similarity suggests that people with a history of the common cold may carry some immunity against SARS-CoV-2 infection, new evidence reveals. Infection with SARS-CoV-2 also boosts production of memory B cells, long-lasting components of immune protection. Even…

Read more

Posted on

FDA OKs Mepolizumab (Nucala) for Hypereosinophilic Syndrome

Posted on

The US Food and Drug Administration (FDA) has expanded the indication for mepolizumab (Nucala, GlaxoSmithKline) to include patients with hypereosinophilic syndrome (HES). Mepolizumab is indicated for adults and children aged 12 years and older with HES for 6 months or longer without an identifiable nonhematologic secondary cause. “[This] approval marks the first time in over a decade…

Read more

Posted on

Survey Quantifies COVID-19’s Impact on Oncology

Posted on

An international survey provides new insights into how COVID-19 has affected, and may continue to affect, the field of oncology. The survey showed that “COVID-19 has had a major impact on the organization of patient care, on the well-being of caregivers, on continued medical education, and on clinical trial activities in oncology,” stated Guy Jerusalem, MD,…

Read more

Posted on

Safety a Concern for Vulvovaginal Atrophy Treatments in Breast Cancer Survivors

Posted on

For women with breast cancer and vulvovaginal atrophy (VVA) unresponsive to non-hormonal therapy, other treatments may be effective, but safety is “controversial and a major concern,” say authors of a systematic review. “I was surprised that clinical studies assessing the safety of the vaginal laser or androgen therapies, with regard to serum estradiol levels or…

Read more

Posted on

Many Advanced Countries Missing Targets for HCV Elimination

Posted on

Eleven high-income countries are on track to meet World Health Organization targets to eliminate hepatitis C infection by 2030, compared with nine countries 2 years ago, researchers report. But 28 countries, including the United States, are not expected to eliminate HCV until 2050. “In the countries making progress, the common elements are political will, a clear national…

Read more